Asian Pacific society of nephrology clinical practice guideline on diabetic kidney disease - executive summary

Liew, Adrian and Bavanandan, Sunita and Prasad, Narayan and Wong, Muh Geot and Chang, Jer Ming and Eiam-Ong, Somchai and Hao, Chuan-Ming and Lim, Chiao Yuen and Lim, Soo Kun and Oh, Kook-Hwan and Okada, Hirokazu and Susantitaphong, Paweena and Lydia, Aida and Tran, Huong Thi Bich and Villanueva, Russell and Yeo, See Cheng and Tang, Sydney C. W. (2020) Asian Pacific society of nephrology clinical practice guideline on diabetic kidney disease - executive summary. Nephrology, 25 (2, SI). pp. 3-11. ISSN 1320-5358, DOI

Full text not available from this repository.


In the 2018 iteration of the United States Renal Data System (USRDS) report, 6 out of the top 10 countries in the world with diabetic kidney disease (DKD) as the cause of end-stage kidney disease (ESKD) were from the Asia-Pacific region, with Malaysia and Singapore topping the charts consistently over the previous years (1). It is, therefore, unsurprising that DKD is a significant healthcare burden for the Asia-Pacific countries, with a considerable amount of the countries’ medical expenditure being spent on kidney replacement therapy (KRT) (2). Specifically, the differences in healthcare infrastructure, resources and cultural beliefs among the Asia-Pacific countries have resulted in the heterogeneity of care and outcomes for people with DKD in the region. The Asian Pacific Society of Nephrology (APSN) consequently commissioned a Working Group (WG) to develop a set of clinical guidelines on the management of DKD, and in particular, to pay attention to nuances of health care across different countries in the region with the aim of making these guidelines applicable and implementable.

Item Type: Article
Uncontrolled Keywords: Nondiabetic Renal-Disease, Low-Protein-Diet, Blood-Pressure Control, All-Cause Mortality, Converting-Enzyme-Inhibition, Angiotensin System Blocker, Speptide-1 Receptor Agonists, Cotransporter 2 Inhibitors, Intensive Glucose Control, To-Creatinine Ratio,
Subjects: R Medicine
Divisions: Faculty of Medicine > Medicine Department
Depositing User: Ms Zaharah Ramly
Date Deposited: 22 Nov 2023 00:53
Last Modified: 22 Nov 2023 01:00

Actions (login required)

View Item View Item